We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company. The Company is engaged in the advancement of treatment applications for cancers throughout the body. It is a producer of Cesium-131 brachytherapy seeds. These seeds are designed to treat a variety of cancers incl... Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company. The Company is engaged in the advancement of treatment applications for cancers throughout the body. It is a producer of Cesium-131 brachytherapy seeds. These seeds are designed to treat a variety of cancers including prostate cancer, head and neck, lung and brain. The Company has also developed a lead-212 generator to secure isotope supply for clinical trials and commercial operations. Its lead-212 generator utilizes the isotope lead-212 to deliver alpha radiation specifically to cancer cells via specialized targeting peptides. The Company is also engaged in the development of imaging diagnostics (Pb-203 (Lead-203)). The Company's melanoma (VMT01) and neuroendocrine tumor (VMT-a-NET) programs are under Phase I/IIa imaging and therapy trials for the treatment of metastatic melanoma and neuroendocrine tumors at various academic institutions. Show more
SEATTLE, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc.Β (βPerspectiveβ or the βCompanyβ) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced...
[212Pb]VMT-Ξ±-NET continued to have a favorable safety profile, with no dose-limiting toxicities observed at the two doses tested (2.5 and 5.0 mCi)Eight of nine patients had durable control of...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.62 | -16.5333333333 | 3.75 | 3.83 | 3.07 | 1263318 | 3.50027615 | CS |
4 | -3.42 | -52.213740458 | 6.55 | 7.0799 | 2.94 | 2780901 | 3.71579809 | CS |
12 | -9.28 | -74.7784045125 | 12.41 | 13.56 | 2.94 | 1460108 | 6.79369407 | CS |
26 | -7.27 | -69.9038461538 | 10.4 | 16.55 | 2.94 | 1122696 | 9.15335125 | CS |
52 | 0.481 | 18.1577953945 | 2.649 | 19.05 | 2.521 | 2679034 | 11.97279237 | CS |
156 | -0.633 | -16.8216848259 | 3.763 | 19.05 | 2.05 | 1741027 | 10.73740377 | CS |
260 | -0.633 | -16.8216848259 | 3.763 | 19.05 | 2.05 | 1741027 | 10.73740377 | CS |
Symbol | Price | Vol. |
---|---|---|
TSLZT Rex 2X Inverse Tesla Daily Target ETF | $ 1.9248 (-7.24%) | 95.77M |
NVDQT Rex 2X Inverse NVIDIA Daily Target ETF | $ 3.75 (2.60%) | 70.62M |
SOXLDirexion Daily Semiconductor Bull 3X Shares | $ 31.13 (-4.24%) | 64.5M |
SPYSPDR S&P 500 | $ 604.29 (-0.41%) | 54.97M |
SPXSDirexion Daily S&P 500 Bear 3X Shares New | $ 5.84 (1.39%) | 52.47M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions